Pfizer and Epocrates announced a collaboration to give healthcare providers mobile access to the Pfizer Medical Information Group to obtain scientific answers to their product questions or to report an adverse event. Clinicians can make direct contact through the Epocrates drug reference app on their iPhone to pharmaceutical manufacturers and immediately apply findings to patient care. Pfizer enables this direct access to its medical information services via the Epocrates channel in an effort to enhance the safe and effective use of its medicines and help improve the quality of patient care.

SRS, a Montvale, N.J.-based maker of hybrid EMRs, announced the launch of its EMR Replacement Program, for medical practices seeking to de-install legacy EMRs. It was created in response to increasing market demand for usable and effective EMRs that boost – rather than reduce – physician productivity. The program has already helped numerous practices transition smoothly from an unsuccessful EMR implementation to the SRS hybrid EMR, company executives say. To ease the financial burden on these practices, which have already made significant investments in one or more EMRs, the EMR Replacement Program offers a unique transfer pricing structure.

eMix, a new business venture from San Diego-based DR Systems, announced that its cloud-based technology for sharing imaging studies and reports has added a new capability: importing and sharing data from CDs, DVDs and other external media. Although eMix replaces the need to share radiology data via hard copy media such as CDs and DVDs, many facilities still receive a significant number of radiology files in CD form. This new innovation now allows institutions to import CD files into eMix, and to use eMix as a convenient place to hold the exams before deciding what they want to do with them.
 
Merge Healthcare announced the launch of a complete workflow solution for imaging in clinical trials. The new CIMS solution is the first open platform in the industry that allows organizations involved in clinical trials to transparently execute the imaging portion of the study within the overall electronic trial management solution. CIMS is the first commercially available Title 21 CFR Part 11-compliant network for managing all aspects of imaging in clinical trials. The CIMS platform automates the full workflow of image submission, image storage in a vendor-neutral DICOM archive, and image analysis and viewers.